VIDEO: ASCO highlights ‘important’ presentations on targeted, immunotherapy in lung cancer

In this video, Ravi Salgia, MD, PhD, discussed findings from two studies, one investigating immunotherapy and the other investigating targeted therapy for the treatment of lung cancer.
The findings were presented at ASCO Annual Meeting.
“What we also find is not only immunotherapy was important in presentations, targeted therapy was incredible important,” Salgia, medical oncologist, and professor and Arthur & Rosalie Kaplan Chair of the department of medical oncology and therapeutics research at City of Hope, said.

In this video, Ravi Salgia, MD, PhD, discussed findings from two studies, one investigating immunotherapy and the other investigating targeted therapy for the treatment of lung cancer.
The findings were presented at ASCO Annual Meeting.
“What we also find is not only immunotherapy was important in presentations, targeted therapy was incredible important,” Salgia, medical oncologist, and professor and Arthur & Rosalie Kaplan Chair of the department of medical oncology and therapeutics research at City of Hope, said.